Assembly Biosciences, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Assembly Biosciences, Inc. (ASMB) had Common Stock, Capital Shares Reserved for Future Issuance of 1.90 million shares as of 2018-05-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Equity › Stockholders' Equity Note › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2019-05-09
- 2018-05-31: Common Stock, Capital Shares Reserved for Future Issuance 1.90M shares.
- 2018-05-30: Common Stock, Capital Shares Reserved for Future Issuance 1.90M shares.
- 2017-04-03: Common Stock, Capital Shares Reserved for Future Issuance 800.00K shares.
- 2014-07-10: Common Stock, Capital Shares Reserved for Future Issuance 2.56M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2018-05-31 | 1.90M shares 10-Q · filed 2019-05-09 |
| 2018-05-30 | 1.90M shares 10-K · filed 2019-02-28 |
| 2017-04-03 | 800.00K shares 10-Q · filed 2018-05-07 |
| 2014-07-10 | 2.56M shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |